The fund is rated 4.5 stars. The strongest areas were investment selection within each asset type and investment selection within each industry, while balance between returns and downside risk provided some support. Above-average fund size of Rs 101,856.06 crore was a minor drawback.
This fund has a good track record with Asset Selection/Timing, a good track record with Stock Selection/Timing. It is important to note, however, that this fund has a 101856.06 AUM and a 1.31 expense ratio. Considering all these factors, we have rated this fund as 4.5 star.
आमचा स्कोअर दीर्घकालीन कामगिरी, जोखीम आणि सातत्य यांचे वजन करतो — फक्त मागील परतावे नाही.
5 Nov 2026 पर्यंत
31 Oct 2026 पर्यंत
30 Sep 2026 पर्यंत
| होल्डिंग | फंडाचा % | मूल्य | शेअर्स |
|---|---|---|---|
| The Federal Bank Ltd. | 3.98% | ₹4,057.17 Cr | 12,78,25,000 |
| AU Small Finance Bank Ltd. | 3.94% | ₹4,014.66 Cr | 3,97,37,347 |
| Max Financial Services Ltd. | 3.52% | ₹3,586.53 Cr | 2,61,14,231 |
| Ipca Laboratories Ltd. | 3.43% | ₹3,495.71 Cr | 1,81,40,659 |
| Glenmark Pharmaceuticals Ltd. | 3.07% | ₹3,130.41 Cr | 1,34,08,183 |
| Balkrishna Industries Ltd. | 2.98% | ₹3,036.04 Cr | 1,43,41,251 |
| Indian Bank | 2.92% | ₹2,970.1 Cr | 3,68,54,482 |
| Coforge Ltd. | 2.68% | ₹2,732.2 Cr | 1,56,20,600 |
| Fortis Healthcare Ltd. | 2.40% | ₹2,441.04 Cr | 3,17,01,862 |
| Marico Ltd. | 2.37% | ₹2,411.17 Cr | 3,06,76,407 |
to generate long-term capital appreciation / income. investment predominantly in Mid-Cap companies.
The scheme seeks to provide long-term capital appreciation/income by investing predominantly in Mid-Cap companies.
Exit load of 1% if redeemed within 1 year.
म्युच्युअल फंड बाजार जोखमीच्या अधीन आहेत. सर्व योजना दस्तऐवज काळजीपूर्वक वाचा.
